Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry.
James TaitSimon ErridgeCarl HolveyRoss CoomberAzfer UsmaniMohammed SajadJonathan HoareShaheen KhanMark WeatherallJames J RuckerMichael PlattMikael Hans SodergrenPublished in: Expert review of neurotherapeutics (2023)
This study observed an association between initiation of CBMP treatment and improved outcomes for chronic pain patients. Prior cannabis use and gender were associated with adverse event incidence. Placebo-controlled trials are still necessary to establish the efficacy and safety of CBMPs for chronic pain.
Keyphrases
- chronic pain
- pain management
- end stage renal disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- placebo controlled
- risk factors
- double blind
- clinical trial
- electronic health record
- big data
- emergency department
- squamous cell carcinoma
- type diabetes
- adipose tissue
- open label
- metabolic syndrome
- patient reported
- artificial intelligence
- patient reported outcomes
- rectal cancer
- phase ii
- glycemic control